Your browser doesn't support javascript.
loading
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo.
Ulges, Alexander; Klein, Matthias; Reuter, Sebastian; Gerlitzki, Bastian; Hoffmann, Markus; Grebe, Nadine; Staudt, Valérie; Stergiou, Natascha; Bohn, Toszka; Brühl, Till-Julius; Muth, Sabine; Yurugi, Hajime; Rajalingam, Krishnaraj; Bellinghausen, Iris; Tuettenberg, Andrea; Hahn, Susanne; Reißig, Sonja; Haben, Irma; Zipp, Frauke; Waisman, Ari; Probst, Hans-Christian; Beilhack, Andreas; Buchou, Thierry; Filhol-Cochet, Odile; Boldyreff, Brigitte; Breloer, Minka; Jonuleit, Helmut; Schild, Hansjörg; Schmitt, Edgar; Bopp, Tobias.
Afiliação
  • Ulges A; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Klein M; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Reuter S; Department of Pulmonary Medicine, III. Medical Clinic of the University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Gerlitzki B; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Hoffmann M; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Grebe N; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Staudt V; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Stergiou N; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Bohn T; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Brühl TJ; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Muth S; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Yurugi H; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Rajalingam K; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Bellinghausen I; Dermatology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Tuettenberg A; Dermatology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Hahn S; Dermatology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Reißig S; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Haben I; Department of Immunology and Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Zipp F; Department of Neurology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Waisman A; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Probst HC; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Beilhack A; Experimentelle Stammzelltransplantation der Medizinische Klinik und Poliklinik II, Zentrum für Experimentelle Molekulare Medizin, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
  • Buchou T; INSERM, U823, Université Joseph Fourier-Grenoble1, Institut Albert Boniot, Faculté de Médecine, Domaine de la Merci, La Tronche, France.
  • Filhol-Cochet O; INSERM U1036, Institute de Recherches en Technologies et Sciences pour le Vivant/Biologie du Cancer et de l'Infection, Commissariat à l'Énergie Atomique et aux Énerigies Alternatives Grenoble, Grenoble, France.
  • Boldyreff B; KinaseDetect, Aarslev, Denmark.
  • Breloer M; Department of Immunology and Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Jonuleit H; Dermatology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Schild H; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Schmitt E; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Bopp T; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Nat Immunol ; 16(3): 267-75, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25599562
ABSTRACT
The quality of the adaptive immune response depends on the differentiation of distinct CD4(+) helper T cell subsets, and the magnitude of an immune response is controlled by CD4(+)Foxp3(+) regulatory T cells (Treg cells). However, how a tissue- and cell type-specific suppressor program of Treg cells is mechanistically orchestrated has remained largely unexplored. Through the use of Treg cell-specific gene targeting, we found that the suppression of allergic immune responses in the lungs mediated by T helper type 2 (TH2) cells was dependent on the activity of the protein kinase CK2. Genetic ablation of the ß-subunit of CK2 specifically in Treg cells resulted in the proliferation of a hitherto-unexplored ILT3(+) Treg cell subpopulation that was unable to control the maturation of IRF4(+)PD-L2(+) dendritic cells required for the development of TH2 responses in vivo.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Células Th2 / Caseína Quinase II Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Células Th2 / Caseína Quinase II Idioma: En Ano de publicação: 2015 Tipo de documento: Article